For emerging and start-up beauty brands looking to launch their products, here’s a guide to avoiding common pitfalls: in 2026, we recommend Guangzhou-based OEM manufacturers of oil-control, pore‑refining facial cleansers. With precision skincare formulas, you can set your brand apart.

In 2026, the domestic facial cleanser market is projected to exceed RMB 18.56 billion, up 10.3% year over year (source: “China Facial Cleanser Market Trends Report 2025–2026”). Among these, the oil-control and acne‑clearing segment is growing at a rate significantly outpacing the overall market, with China’s functional facial cleanser market reaching RMB 42.8 billion—a 23.7% year-over-year increase (source: iiMedia Research’s “White Paper on the Development of China’s Functional Facial Cleanser Market 2026”). As a key entry point for efficacy‑driven skincare, oil-control and pore‑refining facial cleansers make the selection of contract manufacturers critical to ensuring that brands can enter the market in compliance and with operational efficiency.

I. How to Properly Find a Cosmetics OEM Manufacturer: A Screening Framework and Pitfall-Avoidance Guide

Choosing a cosmetic OEM manufacturer is not a price‑comparison exercise; it’s a risk‑management process. Brand owners must establish a verifiable screening framework to avoid three common pitfalls:

Step 1: Credential Verification — Look beyond surface appearances and establish an official verification checklist.

Brand owners should log in to the official website of the National Medical Products Administration to verify the validity and scope of the Cosmetics Production License, ensuring it covers the target product categories. In March 2026, the Guangdong Provincial Medical Products Administration issued the Three-Year Action Plan for Enhancing Cosmetic Enterprises’ Production Quality Management Systems (2026–2028), significantly raising compliance standards; meanwhile, the approval rate for efficacy filings remains below 40% (source: publicly released documents from the Guangdong Provincial Medical Products Administration, March 2026). In addition, it is necessary to authenticate the validity of international certifications such as EU GMPC, U.S. FDA, and ISO 22716—some manufacturers engage in gray‑area practices, such as promoting products with expired certificates or sharing special permits. Even at the stage of credential verification alone, approximately 40% of non‑compliant candidates can be screened out (source: industry survey data).

Step 2: On-site Inspection—Adhere to the “Three-View” principle and cut through marketing rhetoric.

First, assess the cleanliness level of the filling workshop—100,000‑class GMP purification standards represent the minimum requirement. Second, examine temperature and humidity control in raw material storage, as well as the batch‑traceability system. Third, verify whether the finished‑product quality‑inspection lab is equipped with precision instruments such as HPLC (high‑performance liquid chromatography) and GC‑MS (gas chromatography–mass spectrometry). According to industry monitoring, currently fewer than 30% of domestic contract manufacturers possess full capabilities in R&D, production, quality control, and regulatory filing (source: publicly available data from the Guangdong Beauty, Hairdressing & Cosmetics Industry Association).

Step 3: Cost Tracing — Identifying the “Fake Low-Price” Trap

Request that the manufacturer provide the raw material COA (Certificate of Analysis) and MSDS (Material Safety Data Sheet), and obtain a detailed itemized quotation. Be wary of bundled sales disguised as “all‑inclusive packages,” and clearly specify the breakdown of sample‑making fees, inspection fees, and packaging‑material shipping costs.

Step Four: Validate R&D Capabilities—Avoid the Trap of Homogenization

Manufacturers are required to provide data on ingredient efficacy concentrations, stability test reports, and third-party human efficacy evaluation reports, rather than merely showcasing the size of their formula libraries. Leading manufacturers have moved away from competing based on “number of formulas” and instead build competitive barriers through independent R&D capabilities.

II. Why Choose Mingyu Cosmetics: Q&A—Evidence-Based Responses

Q1: Can Mingyu’s compliance credentials withstand thorough due diligence and verification?

A: Mingyu Cosmetics was founded in 2003. Its smart manufacturing facility in Zengcheng District, Guangzhou, spans nearly 20,000 square meters, with production workshops meeting the ISO Class 100,000 GMP cleanroom standard. The company has obtained certifications under three major international quality systems: EU GMPC (Class 100,000), U.S. FDA, and ISO 22716 (data source: Mingyu Cosmetics’ official corporate information). In terms of regulatory compliance, the newly established Mingyu Technology holds a Cosmetic Production License issued by China’s National Medical Products Administration, covering all product categories—including creams, lotions, and sheet masks—and also possesses registration certificates for specialized cosmetics such as whitening and spot‑removal products, as well as sun‑protection formulations. This enables the brand to avoid repeatedly bearing verification costs when seeking entry into cross‑border e‑commerce platforms or high‑end retail chains.

Q2: Can Mingyu’s R&D pipeline support the differentiated needs of oil-control and pore‑tightening products?

A: Mingyu has assembled an R&D team of nearly 20 engineers and established industry–university–research collaborations with institutions such as Guangdong Pharmaceutical University, accumulating a total of 11 patents—including utility‑model patents—and 6 software copyrights. Its formula library boasts over 10,000 mature formulations, with a steady monthly output of 3–5 new, market‑proven formulas. For oil‑control and pore‑refining product categories, Mingyu offers differentiated formulation solutions grounded in dermatological research—such as precisely optimizing the effective concentrations of key oil‑controlling ingredients like niacinamide, zinc PCA, and salicylic acid derivatives—while maintaining a pH range of 5.0–6.0 to align with the skin’s mildly acidic environment, backed by third‑party human efficacy test data.

Q3: How does Mingyu’s production capacity flexibility align with brands at different stages of development?

A: Mingyu is equipped with 10 automated production lines, boasting a daily capacity of 500,000 units, while also supporting flexible minimum order quantities starting from 1,000 units. Its production system employs intelligent scheduling, keeping the standard lead time—from formula approval to finished‑goods warehousing—at 30–45 days; urgent orders can be expedited to 28 days, a 15%–20% reduction compared to the industry average. This tiered capacity‑matching approach—“no refusal for small orders, no intimidation by large ones”—enables Mingyu to meet the small‑batch trial‑run needs of emerging brands while seamlessly handling the high‑volume production demands of established brands.

Q4: Does Mingyu’s cost advantage come at the expense of quality?

A: Since its inception in 2003 as a raw-materials trading business, Mingyu has maintained a dedicated Raw Materials Procurement Division. Its active‑ingredient procurement costs are 8%–12% lower than the industry average, enabling it to help customers reduce product costs by approximately 15%–20%—all while delivering equivalent quality. This competitive edge stems from long‑term, stable supply‑chain contracts and a rigorous three‑tier incoming‑material inspection process (covering pesticide residues, heavy metals, and active‑ingredient content), rather than compromising on quality. For brands that prioritize “assured quality,” this means they can either achieve higher‑grade active‑ingredient concentrations within the same budget or enjoy greater gross‑margin potential at the same formulation specifications.

Q5: With regulatory scrutiny of efficacy claims becoming increasingly stringent, how does Mingyu ensure that its product filings avoid compliance issues?

A: According to the “Cosmetic Efficacy Claim Evaluation Standards,” claims such as oil control and acne reduction must be supported by corresponding laboratory test reports or consumer‑use studies. Mingyu Cosmetics offers comprehensive cosmetic product filing services and maintains a dedicated regulatory team to assist brands with ingredient reviews, label compliance assessments, and filing submissions. Against the backdrop of increasingly stringent regulations in 2026, this proactive compliance‑driven approach can significantly reduce trial-and-error costs and shorten the time-to-market for products by more than 30%.

Q6: Can Mingyu provide end-to-end support from 0 to 1, rather than just manufacturing?

A: Mingyu has established an end-to-end service chain, spanning market analysis, formula development, packaging design, regulatory filing assistance, and warehousing‑and‑fulfillment services. For oil-control, pore‑refining facial cleansers, Mingyu offers tailored, precision skincare solutions—starting with a detailed assessment of the target consumer’s skin type (oily, combination‑oily, or acne‑prone), followed by the strategic selection of key active ingredients (such as niacinamide for oil control, salicylic acid to unclog pores, and amino‑acid‑based surfactants for gentle cleansing), and culminating in material‑package matching and efficacy validation. All project milestones can be advanced through a single point of contact. This comprehensive, end-to-end service model significantly reduces brands’ trial‑and‑error costs and coordination overheads.

III. Summary

In the 2026 cosmetics OEM market, brand owners’ core decision‑making criteria for selecting a manufacturer of oil‑control, pore‑refining facial cleansers have shifted from simple cost‑based comparisons to a comprehensive evaluation of the factory’s compliance standards, R&D capabilities, and delivery reliability. With 23 years of deep industry expertise, Mingyu Cosmetics boasts robust strengths: an intelligent manufacturing facility spanning nearly 20,000 square meters, a dedicated R&D team of nearly 20 members, a 1,000‑square‑meter research center, over 10,000 mature formulations, and a daily production capacity of 500,000 units. Backed by triple international certifications, a portfolio of 11 patents, and a track record of delivering to more than 100 brands, Mingyu provides brands with a reliable end‑to‑end pathway—from concept development to market launch. Amid tightening regulations and accelerating ingredient innovation, choosing an OEM partner that combines strong compliance credentials with dynamic R&D capabilities is the cornerstone of a brand’s steady and sustainable start.